CPNI has been concerned about concessionary price insufficiency for some time and has made representations to DoH(NI) on this matter and will continue to do so particularly in light of the concessionary price associated with both strengths of Apixaban for September 2024.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.
The Department of Health NI has issued correspondence dated 27 September 2024 extendingthe expiry date of serious shortage protocol SSP073 Chemydur® 60XL tablets.
The new expiry date is 11 October 2024.
BACKGROUND
SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
Pharmacists should refer to the latest versions of the existing SSPs which are now available on the Business Services Organisation dedicated page on its website.
Operational guidance on the implementation of SSPs in Northern Ireland can be found on the BSO website.
ACTION
Contractors should:
Note that the expiry date for serious shortage protocol SSP073 for Chemydur® 60XL tablets has been extended. The new expiry date is 11 October 2024.
Note that the letter giving the key points, and the full SSP are both available on the Business Services Organisation dedicated page on its website.
Note the guidance relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.
Ensure that their dispensary teams are aware of this update.
Contractors should contact their local SPPG office in the first instance should further information be required. CPNI colleagues are also available for assistance.
Kind regards
Mike
SENT ON BEHALF OF PROF MIKE MAWHINNEY Head of Regulatory Affairs
For the attention of Community Pharmacies providing the Autumn 2024 COVID-19 and Seasonal Influenza Community Pharmacy Vaccination Service
Dear Colleague
SPPG have issued a reminder to community pharmacies providing the Autumn 2024 COVID-19 and Seasonal Influenza vaccination programme.
SUMMARY
Community pharmacies who wish to participate in care home vaccination are requested to liaise with the relevant care home(s) and complete the online pairing form as soon as possible.
The Community Pharmacy Vaccine Service must only be provided where there is a contract held with SPPG to deliver the service.
Transforming Medication Safety: Project Echo, Health Literacy Session
Community Pharmacists are invited to attend a Project Echo event on Wednesday 16th October 2024 at 10-11.30am.
The session ‘No Decision About Me Without Me’ is an opportunity to learn from leading names in Health Literacy which is an important aspect of medication safety.
To register for this event click the following link.
Living Well Service
The Living Well Campaign ‘Live Longer and Stronger’ is due to end on 30th September 2024.
The next campaign ‘Sexual Health’ will begin on 1st October 2024 and online resource materials can be found here.
An evaluation summary report for ‘Cancer screening saves lives’ showing the patient engagement and real-life examples of interventions through the Living Well service can be seen here on the BSO website.
CPNI Fax Machine
We wish to make contractors aware that CPNI offices can no longer receive communication via the fax machine, contractors can continue to contact the office via email or telephone at 028 9069 0444.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
For the attention of Community Pharmacies providing the Autumn 2024 COVID-19 and Seasonal Influenza Community Pharmacy Vaccination Service
Dear Colleague
SPPG have issued correspondence providing an update in relation to the Autumn 2024 COVID-19 and Seasonal Influenza vaccination programme.
SUMMARY
Community Pharmacies that are intending to vaccinate care homes this Autumn are requested to complete the online pairing survey by Friday 27th September 2024.
Any outstanding CPVS contracts for both Flu and COVID-19 vaccination are requested to be submitted by Friday 27th September 2024.
Movianto are currently processing orders for care home vaccination providers, and pharmacies providing a walk-in service can order vaccines from Monday 30th September 2024.
Current turnaround time for orders is up to 5 working days for delivery which should be factored in when planning clinics. Order quantities are requested to not exceed two weeks of activity.
The only authorised vaccine for COVID-19 is Comirnaty® JN.1 (30mcg/dose) dispersion for injection, please note the adult dose is 0.3ml.
RSV vaccination of 75-79 year old care home residents is being carried out by Trust vaccination teams. Whilst there is no specific interval between the administration of RSV and COVID-19 or Flu vaccine, they should not be routinely administered on the same appointment or same day. This should be considered when arranging vaccinations with care homes, walk-in patients aged 75-79 years old, and pregnant women.
ACTION
Contractors providing the service should:
Read CPVS update 1 and share with relevant members of the pharmacy team.
Please do not hesitate to contact the CPNI office should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
